IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Connect Biopharma Hldgs LTD

CUSIP: 207523101 | 85 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AIkarian Capital, LLC4,338,5346.9%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/AWei Zheng2,520,3594.0%Newly reportedJun 30, 2026No 13F filer matched
13G/AIkarian Capital, LLC4,338,534
6.9% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched
13G/AWei Zheng2,520,359
4.0% of class · Jun 30, 2026Newly reported
No 13F filer matched

Institutional Holders — Q2 2026

Quadrature Capital Ltd42,303
0.0% of portfolio›$100.7K
StyleTurnoverLocationFiled
Quadrature Capital Ltd
42,303$100.7K0.0%GARPVery HighLondon, United Kingdom2026-08-07